Replies to post #1377 on PDS Biotechnology Corp (PDSB)

[Fress]

PDS Biotechnology Expands VERSATILE-002 study of PDS0101 and KEYTRUDA® in Advanced Head and Neck Cancer to Include Patients Who Have Failed Prior Treatment with Checkpoint Inhibitors
https://finance.yahoo.com/news/pds-biotechnology-expands-versatile-002-125300514.html


$PDSB